Current and emerging treatment options in primary mediastinal B-cell lymphoma
B Fakhri, W Ai - Therapeutic Advances in Hematology, 2021 - journals.sagepub.com
Previously considered a subtype of diffuse large B-cell lymphoma (DLBCL), primary
mediastinal B-cell lymphoma (PMBCL) is now recognized by the World Health Organization …
mediastinal B-cell lymphoma (PMBCL) is now recognized by the World Health Organization …
Rituximab: 13 open questions after 20 years of clinical use
F Pavanello, E Zucca, M Ghielmini - Cancer treatment reviews, 2017 - Elsevier
Rituximab improved the prognosis of all B-cell derived lymphoproliferative diseases, but
despite 20 years of intensive use, it remains a drug with a number of still obscure …
despite 20 years of intensive use, it remains a drug with a number of still obscure …
[HTML][HTML] Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial
M Gleeson, N Counsell, D Cunningham, N Chadwick… - Annals of …, 2017 - Elsevier
Background Central nervous system (CNS) relapse of diffuse large B-cell lymphoma
(DLBCL) is associated with a dismal prognosis. Here, we report an analysis of CNS relapse …
(DLBCL) is associated with a dismal prognosis. Here, we report an analysis of CNS relapse …
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
Primary mediastinal B-cell lymphoma (PMBL) is a rare type of aggressive lymphoma
typically affecting young female patients. The first-line standard of care remains debated. We …
typically affecting young female patients. The first-line standard of care remains debated. We …
Identification of very low-risk subgroups of patients with primary mediastinal large B-cell lymphoma treated with R-CHOP
TP Vassilakopoulos, M Michail, S Papageorgiou… - The …, 2021 - academic.oup.com
Background R-CHOP can cure approximately 75% of patients with primary mediastinal large
B-cell lymphoma (PMLBCL), but prognostic factors have not been sufficiently evaluated yet …
B-cell lymphoma (PMLBCL), but prognostic factors have not been sufficiently evaluated yet …
Primary mediastinal large B-cell lymphoma
A Dabrowska-Iwanicka, JA Walewski - Current hematologic malignancy …, 2014 - Springer
Primary mediastinal B-cell lymphoma (PMBCL) is a relatively rare lymphoma subtype
affecting mainly young adults. Its molecular signature and clinical features resemble …
affecting mainly young adults. Its molecular signature and clinical features resemble …
Primary mediastinal large B-cell lymphoma
VR Bhatt, R Mourya, R Shrestha, JO Armitage - Cancer Treatment Reviews, 2015 - Elsevier
The management of primary mediastinal large B-cell lymphoma (PMBCL) requires a
balance between optimizing chances of cure and reducing risk of long-term toxicities. The …
balance between optimizing chances of cure and reducing risk of long-term toxicities. The …
Primary mediastinal B-cell lymphoma: novel precision therapies and future directions
H Chen, T Pan, Y He, R Zeng, Y Li, L Yi, H Zang… - Frontiers in …, 2021 - frontiersin.org
Primary mediastinal large B-cell lymphoma (PMBCL) is a distinct clinicopathologic disease
from other types of diffuse large B-cell lymphoma (DLBCL) with unique prognostic features …
from other types of diffuse large B-cell lymphoma (DLBCL) with unique prognostic features …
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies
TP Vassilakopoulos, SG Papageorgiou… - Annals of …, 2021 - Springer
Abstract End-of-treatment (EoT) PET/CT is used as a guide to omit radiotherapy (RT)
patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature …
patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature …
Risk of CNS dissemination in extranodal lymphomas
AJM Ferreri - The Lancet Oncology, 2014 - thelancet.com
Extranodal lymphomas constitute a heterogeneous group of malignancies, accounting for
roughly 60% of all non-Hodgkin lymphomas. The extranodal organ where lymphomas arise …
roughly 60% of all non-Hodgkin lymphomas. The extranodal organ where lymphomas arise …